CYP19A1 and obesity disorder: Obesity-associated chronic metabolic dysfunctions are considered to be major contributing factors for the carcinogenesis and progression of EC through various mechanisms, including insulin resistance, increased amount of visceral adipose tissue and serum adipokines, activated aromatase signaling pathways, and an elevated chronic inflammatory status (27–29).